AMITIZA, THE FIRST SELECTIVE CHLORIDE CHANNEL ACTIVATOR FOR THE TREATMENT OF CHRONIC IDIOPATHIC CONSTIPATION

A A

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc., announced today that AMITIZA (lubiprostone), 24-mcg soft-gel capsules, approved by the U.S. Food and Drug Administration (FDA) in January 2006, is now available by prescription in pharmacies across the United States for the treatment of chronic idiopathic constipation in adults.
Market Wire